Clinical trial
Retrospective Study of Functional Benefits of Individualized Multisite Neuro-Orthopedic Upper Limb Surgery in Children With Unilateral Cerebral Palsy
NCT07891078 is registered in ClinicalTrials.gov with Centre Médico-Chirurgical de Réadaptation des Massues Croix Rouge Française as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Retrospective Study of Functional Benefits of Individualized Multisite Neuro-Orthopedic Upper Limb Surgery in Children With Unilateral Cerebral Palsy
- Lead sponsor
- Centre Médico-Chirurgical de Réadaptation des Massues Croix Rouge Française
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- July 1, 2026
- Completion date
- December 1, 2026
- Enrollment
- 70 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
Arms
As registered; 1 arm.
-
Children with Unilateral Cerebral Palsy - Multisite Upper Limb Surgery
Retrospective cohort of children with unilateral cerebral palsy (hemiplegia) who underwent individualized multisite neuro-orthopedic upper limb surgery at the Centre des Massues between January 2012 and June 2025. Surgical procedures were individualized and may include one or more of the following: short adductor of thumb release, flexor carpi ulnaris (FCU) release, FCU transfer to extensor carpi radialis brevis, finger flexor lengthening, round pronator release, elbow flexor lengthening, wrist arthrodesis, and other procedures. All patients underwent pre-surgical multidisciplinary evaluation, specialized surgery, and structured post-operative rehabilitation including orthoses and occupational therapy.
Primary endpoints
Registered primary outcome measures; 1 primary.
-
Upper Limb Range of Motion and Dexterity - Modified Melbourne Assessment (MA2)
Scores for the "Range of Motion" and "Dexterity" dimensions of the Modified Melbourne Assessment version 2 (MA2). The MA2 evaluates unilateral upper limb quality of function during tasks involving object approach, grasp, release, and manipulation in children aged 2.5 to 15 years with neurological impairment. Assessment is video-recorded during routine clinical care and scored retrospectively by an occupational therapist. Results are expressed as percentages for each of the four MA2 domains. Inter-rater reliability is excellent (R=0.95) and intra-rater reliability is very good (R=0.97).
Lead sponsor's other trials
Centre Médico-Chirurgical de Réadaptation des Massues Croix Rouge Française, most recent start first.
+6 more trials See the organization page
Similar trials
Same condition (Hemiplegia) and phase, most recent start first.
+61 more trials See the condition page